© Copyright - Newspaper WordPress Theme by TagDiv
Ipratropium Bromide
Also known as / Synonyms: Ipratropium, SAMA (Short-Acting Muscarinic Antagonist)
Short-acting muscarinic antagonist (SAMA) bronchodilator relieving bronchospasm in COPD and acute asthma.
Clinical Snapshot & Specifications
Approved Indications & Medical Uses
- Maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
- Acute bronchospasm in asthma exacerbations (adjunct to short-acting beta-2 agonists).
- Rhinorrhea associated with allergic or perennial rhinitis (nasal spray formulation).
Contraindications (Do Not Use If…)
- Known hypersensitivity to ipratropium bromide, atropine, or other belladonna alkaloids.
- Known allergy to soya lecithin or peanuts (in older CFC formulations; HFA inhalers generally safe).
Important Clinical Precautions & Warnings
- Paradoxical bronchospasm: may occur immediately after inhalation; discontinue immediately and treat with fast-acting beta-2 agonist.
- Ocular complications: avoid mist/spray entering eyes; can cause pupil dilation (mydriasis), increased intraocular pressure, and acute angle-closure glaucoma.
- Urinary retention and prostatic hyperplasia: use with caution in patients with bladder neck obstruction or BPH.
- Not for rapid monotherapy: onset is slower (15-30 min) than albuterol/levosalbutamol; pair with beta-agonists in acute emergencies.
Special Populations (Paediatric & Geriatric Care)
Pediatric: Approved for acute asthma in nebulized form under medical supervision. Elderly: Increased susceptibility to anticholinergic effects (urinary hesitation, constipation).
Side Effects & Adverse Reactions
Common Side Effects (Usually Mild)
Dry mouth, throat irritation, cough, bitter taste, headache, dizziness, nausea, and mild tachycardia.
Serious Side Effects — Seek Urgent Medical Care
Acute narrow-angle glaucoma, severe urinary retention, paradoxical bronchospasm, atrial fibrillation/supraventricular tachycardia, and angioedema.
Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.
Drug, Food & Substance Interactions
- Other anticholinergics (tiotropium, aclidinium, glycopyrronium): additive systemic anticholinergic adverse effects; avoid co-administration.
- Beta-2 agonists (salbutamol, formoterol): beneficial synergistic bronchodilation without increased adverse events.
Pregnancy & Lactation Clinical Safety
Pregnancy Safety:
Use with caution — see notesMinimal systemic absorption following inhalation; animal reproduction studies show no teratogenicity. Use when clinically needed.
Lactation & Breastfeeding:
Use with caution — see notesSystemic concentrations are negligible; unlikely to pass into breast milk in detectable quantities.
Storage, Administration & Overdose Protocol
🌡️ Recommended Storage:
Store inhaler between 20°C and 25°C. Avoid exposing pressurized canister to open flame or temperatures > 50°C.
⏱️ Missed Dose Protocol:
Take standard maintenance dose (2 puffs 4 times daily). If forgotten, take upon remembering unless time for next inhalation.
Because of minimal systemic absorption, acute systemic anticholinergic toxicity is rare. Manifestations may include dry mouth, visual accommodation disturbances, and tachycardia. Provide supportive care.
